Intravenous heparin dosing
- 1 October 1993
- journal article
- review article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 8 (10) , 536-542
- https://doi.org/10.1007/bf02599634
Abstract
Objective: To characterize internists’ dosing practices when administering and adjusting intravenous heparin regimens.Design: A survey administered by physician-investigators.Setting: Two community teaching hospitals and one Veterans Affairs Medical Center. Subjects: Sixty-one attending physicians in internal medicine.Measurements: Physicians’ choices of therapeutic activated partial thromboplastin time (APTT) range, initial heparin bolus, initial infusion dose, and dose/infusion adjustments when APTT levels are 90 seconds). Results: Physicians’ dosing decisions and therapeutic ranges during heparin treatment varied widely. Responses to nontherapeutic APTT levels had especially high coefficients of variation (0.67 – 0.81). Two groups of physicians, together comprising a majority of all respondents, use mutually exclusive therapeutic ranges (mean 44–56 seconds and 60–83 seconds). These two groups differ significantly in several types of dosing decisions. Conclusion: In the absence of generalizable standard guidelines for intravenous heparin therapy, internists’ dosing practices vary widely. Because such practices may impede timely, effective anticoagulation, experimental studies comparing standardized dosing protocols are needed.Keywords
This publication has 49 references indexed in Scilit:
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Circadian changes in anticoagulant effect of heparin infused at a constant rate.BMJ, 1985
- Audit of control of heparin treatment.BMJ, 1985
- Heparin therapy for thromboembolic disorders. A prospective evaluation of 134 cases monitored by the activated coagulation timeJAMA, 1983
- Sources of error in heparin therapy of thromboembolic diseaseArchives of internal medicine (1960), 1980
- Heparin therapy: A randomized prospective studyAmerican Heart Journal, 1979
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976
- Assessment of Anticoagulant Treatment of Venous ThromboembolismAnnals of Surgery, 1969